Gregory Russotti
Hoofd Techniek/Wetenschap/O&O bij CENTURY THERAPEUTICS, INC.
Vermogen: 1 M $ op 31-05-2024
Actieve functies van Gregory Russotti
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CENTURY THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 | - |
| Algemeen Directeur | 11-04-2023 | 04-12-2023 | |
| President | 11-04-2023 | 04-12-2023 | |
Dynamk Capital LLC
 Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York. | Consultant / Adviseur | - | - |
Loopbaan van Gregory Russotti
Eerdere bekende functies van Gregory Russotti
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | 01-10-2017 | 31-12-2019 |
Opleiding van Gregory Russotti
| Rensselaer Polytechnic Institute | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| President | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CENTURY THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Dynamk Capital LLC
Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York. | Finance |
- Beurs
- Insiders
- Gregory Russotti
- Ervaring
